上海医药：子公司取得药品上市许可

南方财经网2025-12-10

南财智讯12月10日电，上海医药公告，公司下属上海上药信谊药厂有限公司收到国家药品监督管理局下发的《药品注册证书》，其提交的苹果酸司妥吉仑片（即SPH3127片）的药品上市许可申请已获批准。该药品为化学药品1类，适用于原发性高血压的治疗，相关项目累计已投入研发费用约2.96亿元。本次获批标志着子公司具备在国内市场生产和销售该药品的资格，但后续生产与销售可能受到市场、政策及竞争环境等不确定性因素影响...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2590301278?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-10 15:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590301278","market":"hk","top_or_hot":-1,"title":"上海医药：子公司取得药品上市许可","media":"南方财经网","content":"<div>\n<p>南财智讯12月10日电，上海医药公告，公司下属上海上药信谊药厂有限公司收到国家药品监督管理局下发的《药品注册证书》，其提交的苹果酸司妥吉仑片（即SPH3127片）的药品上市许可申请已获批准。该药品为化学药品1类，适用于原发性高血压的治疗，相关项目累计已投入研发费用约2.96亿元。本次获批标志着子公司具备在国内市场生产和销售该药品的资格，但后续生产与销售可能受到市场、政策及竞争环境等不确定性因素影响...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202512103587664274.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>上海医药：子公司取得药品上市许可</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n上海医药：子公司取得药品上市许可\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-10 15:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202512103587664274.html><strong>南方财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>南财智讯12月10日电，上海医药公告，公司下属上海上药信谊药厂有限公司收到国家药品监督管理局下发的《药品注册证书》，其提交的苹果酸司妥吉仑片（即SPH3127片）的药品上市许可申请已获批准。该药品为化学药品1类，适用于原发性高血压的治疗，相关项目累计已投入研发费用约2.96亿元。本次获批标志着子公司具备在国内市场生产和销售该药品的资格，但后续生产与销售可能受到市场、政策及竞争环境等不确定性因素影响...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202512103587664274.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0099","symbol_name":"上海本地重组","start_time":0,"source_url":"http://finance.eastmoney.com/a/202512103587664274.html","article_id":"2590301278","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590301278","pubTimestamp":1765353188,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"南财智讯12月10日电，上海医药公告，公司下属上海上药信谊药厂有限公司收到国家药品监督管理局下发的《药品注册证书》，其提交的苹果酸司妥吉仑片（即SPH3127片）的药品上市许可申请已获批准。该药品为化学药品1类，适用于原发性高血压的治疗，相关项目累计已投入研发费用约2.96亿元。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601607":"上海医药","BK0099":"上海本地重组","BK0028":"国家队","BK0097":"医药电商","BK1197":"保健护理产品经销商","BK0020":"浦东新区","BK0209":"零售","BK0183":"MSCI概念","BK0187":"一线龙头","BK0188":"融资融券","02607":"上海医药","BK0012":"证金概念","BK0196":"行业龙头","BK0175":"白马股","BK0184":"上海国资改革"},"translate_title":"Shanghai Pharmaceuticals: Subsidiary obtains drug marketing authorization","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1.5,"02607":1.5},"content_text":"南财智讯12月10日电，上海医药公告，公司下属上海上药信谊药厂有限公司收到国家药品监督管理局下发的《药品注册证书》，其提交的苹果酸司妥吉仑片（即SPH3127片）的药品上市许可申请已获批准。该药品为化学药品1类，适用于原发性高血压的治疗，相关项目累计已投入研发费用约2.96亿元。本次获批标志着子公司具备在国内市场生产和销售该药品的资格，但后续生产与销售可能受到市场、政策及竞争环境等不确定性因素影响。 （文章来源：南方财经网）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590301278","isCrawlerRequest":true}